Co-Diagnostics Reports Q3 2024 Financial Results
Co-Diagnostics ( (CODX) ) has released its Q3 earnings. Here is a breakdown of the information Co-Diagnostics presented to its investors.
Positive Outlook for Rocket Pharmaceuticals Amidst Significant Trial Progress and Regulatory Engagement
TD Cowen analyst Tyler Van Buren has maintained their bullish stance on RCKT stock, giving a Buy rating today. Tyler Van Buren has given his ...
Ventures Africa1h
National Basketball Association (NBA) Africa and Agence Française de Développement (AFD) Launch Youth Development Program in Senegal
Former NBA Player and 2015 FIBA AfroBasket Champion Olumide Oyedeji Attends Launch – NBA Africa ( and Agence Française de ...
Bloomberg L.P.22h
Dimensional International Vector Equity ETF
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...